AAAAAA
Results:
1-7
|
Results: 7
Authors:
La Du, BN
Billecke, S
Hsu, C
Haley, RW
Broomfield, CA
Citation: Bn. La Du et al., Serum paraoxonase (PON1) isozymes: The quantitative analysis of isozymes affecting individual sensitivity to environmental chemicals, DRUG META D, 29(4), 2001, pp. 566-569
Authors:
Sorenson, RC
Bisgaier, CL
Aviram, M
Hsu, C
Billecke, S
La Du, BN
Citation: Rc. Sorenson et al., Human serum paraoxonase/arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids - ApolipoproteinA-I stabilizes activity, ART THROM V, 19(9), 1999, pp. 2214-2225
Authors:
Aviram, M
Rosenblat, M
Billecke, S
Erogul, J
Sorenson, R
Bisgaier, CL
Newton, RS
La Du, B
Citation: M. Aviram et al., Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants, FREE RAD B, 26(7-8), 1999, pp. 892-904
Authors:
Haley, RW
Billecke, S
La Du, BN
Citation: Rw. Haley et al., Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans, TOX APPL PH, 157(3), 1999, pp. 227-233
Authors:
Sorenson, RC
Aviram, M
Bisgaier, CL
Billecke, S
Hsu, C
La Du, BN
Citation: Rc. Sorenson et al., Properties of the retained N-terminal hydrophobic leader sequence in humanserum paraoxonase arylesterase, CHEM-BIO IN, 120, 1999, pp. 243-249
Authors:
La Du, BN
Aviram, M
Billecke, S
Navab, M
Primo-Parmo, S
Sorenson, RC
Standiford, TJ
Citation: Bn. La Du et al., On the physiological role(s) of the paraoxonases, CHEM-BIO IN, 120, 1999, pp. 379-388
Authors:
Naguib, M
Gomaa, M
Samarkandi, AH
Bevan, DR
Akkielah, AK
Watson, C
Billecke, S
La Du, BN
Citation: M. Naguib et al., Increased plasma cholinesterase activity and mivacurium resistance: Reportof a family, ANESTH ANAL, 89(6), 1999, pp. 1579-1582
Risultati:
1-7
|